Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06799039 · ClinicalTrials.gov registry record · Early Phase 1
Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease
A Early Phase 1 study, sponsored by Brigham and Women's Hospital.
- Not yet
- Registry status
- Early Phase 1
- Development phase
- 69
- Enrollment target
NCT06799039: Clinical Trial Early Phase 1 study, sponsored by Brigham and Women's Hospital.
NCT06799039 is a Early Phase 1 study that has not yet begun recruiting, run by Brigham and Women's Hospital. The registered enrollment target is 69 participants, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (30% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06799039, a Early Phase 1 study, has not yet begun recruiting, sponsored by Brigham and Women's Hospital.
- NOT YET RECRUITING
- Registry status
- Early Phase 1
- Development phase
- 69 participants
- Enrollment target
Study Summary
This 3+3 dose escalation pilot trial will assess the safety and efficacy of xylitol as an oral therapeutic for decolonization of C. difficile in the Inflammatory Bowel Disease (IBD) patient population.
Primary Outcome
Incidence of Treatment Emergent Adverse Events (TEAEs) through Week 8
Interventions
- DRUG Xylitol
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 69 participants |
| Start Date | 2026-09-01 |
| Est. Completion | 2031-09-01 |
| Phase | Early Phase 1 |
What is known before NCT06799039 opens enrollment
NCT06799039 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 69 participants, a relatively small participant target, above the 53-participant average among 2,764 other Early Phase 1 trials with a reported enrollment target (30% higher).
The record links to 0 conditions, and to 1 intervention - of which Xylitol is the first listed.
NCT06799039 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06799039 about?
NCT06799039 is a clinical study titled "Pilot Trial of Xylitol for C. Difficile De-Colonization in Patients With Inflammatory Bowel Disease". This 3+3 dose escalation pilot trial will assess the safety and efficacy of xylitol as an oral therapeutic for decolonization of C. difficile in the Inflammatory Bowel Disease (IBD) patient population.
What is the current status of trial NCT06799039?
This trial is currently not yet recruiting. It is a Early Phase 1 study. The enrollment target is 69 participants. The study started on 2026-09-01. Estimated completion is 2031-09-01.
What interventions are being tested in trial NCT06799039?
The interventions under investigation include: Xylitol (DRUG).
Who is sponsoring clinical trial NCT06799039?
This trial is sponsored by Brigham and Women's Hospital, which has 937 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06799039's enrollment target sits among peer trials
69 355th of 2000 higher than 1,644 of 2,000 other Early Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Early Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04020575 · 69 participants · Phase 1
Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)
- NCT04163614 · 69 participants · NA
Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients
- NCT04164641 · 69 participants · NA
Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration
- NCT04493372 · 69 participants · NA
Deciphering Preserved Autonomic Function After Spinal Cord Injury
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI